← Back to search

Entrada Therapeutics Inc

TRDA · NASDAQ

Research and Development in Biotechnology

ESG Scores

Overall ESG

7.1

Environmental

6.5

Social

4.2

Governance

6.2

Gender Diversity

Female Directors0.25%

CEO GenderMale

Market Data

Price$6.46+0.12 (+1.89%)

Market Cap—

P/E Ratio—

EPS$—

52W High$—

52W Low$—

Beta—